Chief Technology Officer /Chief Operating Officer
Mr. Owens is an experienced leader of Innovation Centers focused on research, product development, software engineering, and IT operations in the pharmaceutical research and medical device industries. He has a record of accomplishment of leading and developing people and organizations transform cutting edge technology into innovative products and services. He previously built and led software development organizations for Siemens Healthcare, RadPharm (now Bioclinica), and Forest Laboratories.
Dr. Udupa has 38 years of professional research experience in the areas of image processing, computer vision, and medical imaging. He is recognized for developing fundamental computational theories and algorithm in these areas, developing and distributing large open-source software systems, and bringing 3D image analysis techniques into a variety of medical application areas. He is the chief architect of the ideas and the design behind the Automatic Anatomy Recognition (AAR) technology.
Dr. Torigian is a physician-scientist in the Department of Radiology with expertise in thoracic imaging, body CT, body and musculoskeletal MRI, cardiovascular imaging, and PET/CT imaging. His research focuses on quantification of pulmonary and abdominal diseases by CT and MR imaging using computer-assisted techniques, includes quantification of diseases of various parts of the body using software to analyze PET/CT images. Dr. Torigian has worked closely with Dr. Udupa for over 10 years and in developing the AAR technology.
Mr. Camaratta specializes in medical technology innovation and commercialization, taking products from concept to clinical adoption. He built businesses for GE Healthcare and Siemens Healthcare (among others) with revenues in the $10 to $300 million range. He holds an MS in Computer Science, and has led product management and development efforts in a regulated environment. Mr. Camaratta serves on a number of committees supporting investment in early stage technologies, and is responsible for the day-to-day operations of the company.
Michael Dishowitz, Ph.D.
Dr. Dishowitz manages a portfolio of PCI Ventures startup companies, focusing on the medical device, biotechnology, and therapeutic sectors. His primary responsibility is to build businesses that commercialize Penn intellectual property by recruiting management, developing business strategies, fundraising, supporting company operations, and executing deals. He is also the director of Penn’s medical device startup accelerator, DevelUPmed, and manages several capital acquisition and business development programs.
Mr. Posner is a public company Chief Financial Officer (CFO) with experience in fund-raising and building strategic partnerships. He is strategic and financial leader with over 25 years of diversified management experience working in both public and private companies ranging from start-up to $1 billon. Mr. Posner is skilled at assisting teams achieve organizational goals, with strong experience in capital raising, business development, and acquisition transactions.
Ms. Pednekar holds a Masters of Biomedical Engineering from Drexel University, and completed an internship at Dr. Udupa’s Medical Imaging Processing Group laboratory where she developed algorithms for quantification of thoracic objects. She has strong knowledge of human anatomy and understanding of regulations that need to be addressed during product development and commercialization.
CEO and President, Adaptive Clinical Systems. Mr. Adibi is a Senior Technology leader with 20+ years experience translating market demands and company business strategy into actionable technology framework. Experience in marketing, technology image, and service reputation enhancements for product and services in regulated environments.
President & CEO, iOnTrends, Inc. Mr. Falkenstein brings extensive customer relations world wide in radiation oncology and imaging devices. He has proven experience in marketing, communications, sales and service of medical products, and strategies for FDA clearance and re-imbursement.
Charles Simone, MD
Medical Center Director, University of Maryland Proton Therapy Center. Dr. Simone is nationally recognized expert in proton therapy, with focus on adaptive radiotherapy planning. He has extensive experience in development of clinical trial strategies and research protocols.
Yubing Tong (佟雨兵), Ph.D.
Senior Research Investigator & Director of Operations, Medical Image processing Group (MIPG) at Radiology Department, University of Pennsylvania. Dr. Tong has over 10 years of working experience in computer vision, medical image processing and machine learning fields with more than 100 publications. Dr. Tong serves as a peer reviewer for over 20 international journals and a program committee member for over 10 international conferences. He also serves for NSF as a grant reviewer.